Diminished Ef fi cacy of Programmed Death-(Ligand)1 Inhibition in STK11 - and KEAP1 -Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status
暂无分享,去创建一个
S. Digumarthy | M. Tolstorukov | A. Cherniack | M. Hellmann | D. Barbie | M. Nishino | L. Sholl | J. Egger | L. Spurr | H. Rizvi | J. Gainor | F. Skoulidis | M. Awad | A. Plodkowski | G. Recondo | M. Altan | N. Vokes | Amir Vajdi | Yvonne Y. Li | B. Ricciuti | Jessica J. Lin | K. Arbour | S. Khosrowjerdi | G. Lamberti | Hyesun Park | J. Alessi | V. Vaz | L. Hong | Jianjun Zhang | D. Venkatraman | Xinan Wang | N. Vaz | J. Heymach | Liam F. Spurr